Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1

Conditions

Breast Neoplasms 15Vitamin D Deficiency 13Prostatic Neoplasms 13Polycystic Ovary Syndrome 8Neoplasms 7Osteoporosis 4Colorectal Neoplasms 4Warts 3Rectal Neoplasms 3Ovarian Neoplasms 3Myelodysplastic Syndromes 3Leukemia, Lymphocytic, Chronic, B-Cell 3Colonic Neoplasms 3Brain Neoplasms 3Male Urogenital Diseases 2Leukemia 2Cardiovascular Diseases 2Adenomatous Polyps 2Stroke 1Spinal Cord Injuries 1Skin Neoplasms 1Seizures 1Psoriasis 1Prostate Adenocarcinoma 1Premature Birth 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Polyps 1Pathologic Processes 1Pain 1Osteoarthritis 1

Interventions

Cyclophosphamide 29fludarabine phosphate 27Peripheral Blood Stem Cell Transplantation 23Busulfan 23Antilymphocyte Serum 19Tacrolimus 18Radiotherapy 16Methotrexate 16Filgrastim 15Etoposide 14Mycophenolic Acid 12Cyclosporine 12Whole-Body Irradiation 11Methylprednisolone 11Melphalan 11Cytarabine 10Psychiatric Rehabilitation 9sargramostim 6Therapeutics 6Cord Blood Stem Cell Transplantation 6Flow Cytometry 5Alemtuzumab 5Thiotepa 4Thalidomide 4Sirolimus 4Early Intervention, Educational 4Cyclosporins 4thymoglobulin 3aldesleukin 3Tretinoin 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative × Cholecalciferol × Clear all
NCT00068276 2018-08-10

Cholecalciferol in Treating Patients With Myelodysplastic Syndrome

Wake Forest University Health Sciences

Phase 2 Completed
MyeloidOther hematologic neoplasm

Leukemia, Myelodysplastic Syndromes, Myeloproliferative Disorders, Myelodysplastic-Myeloproliferative Diseases, Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative

Data powered by HemOnc (CC BY 4.0) Colophon âš¡